Eli Lilly Long Term Debt 2012-2026 | LLY

Eli Lilly long term debt for the quarter ending March 31, 2026 was $40.868B, a 43.26% increase year-over-year.

  • Eli Lilly long term debt for 2025 was $40.868B, a 43.26% increase from 2024.
  • Eli Lilly long term debt for 2024 was $28.527B, a 55.71% increase from 2023.
  • Eli Lilly long term debt for 2023 was $18.321B, a 24.31% increase from 2022.

Eli Lilly Long Term Debt 2012-2026 | LLY

  • Eli Lilly long term debt for 2025 was $40.868B, a 43.26% increase from 2024.
  • Eli Lilly long term debt for 2024 was $28.527B, a 55.71% increase from 2023.
  • Eli Lilly long term debt for 2023 was $18.321B, a 24.31% increase from 2022.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B